The Metabolomics Shared Resource (MeSR) provides UHCC members and researchers with premium access to expert advice, consultation and technical support services to enable use of advanced metabolomics and bioinformatics technologies for studies spanning the entire range of cancer research areas represented in the center. Research conducted by UHCC investigators requires measurements of endogenous metabolites to discover associations with biological outcomes or disease risk and ensure the consistency and relevance of in vitro models. These studies span various genetic mutations, ?lifestyle? exposures (diet, smoking), and natural product interventions. Measurement of a large panel of metabolites or metabolite markers in biological samples requires sophisticated instrumentation and technical expertise. Mass spectroscopic (MS)-based metabolic profiling approaches have been increasingly applied to in an attempt to understand how metabolome of mammalian biofluids (serum/plasma or urine), tumor tissues, cell lines (lysates) alter as a result of metabolic transformation in cancer. Challenges remain in the application of MS metabolic profiling to routine cellular, clinical and biomedical studies. Our overall hypothesis is that an MS-based, high-throughput metabolomics platform can identify and characterize metabolite markers and mechanistic pathways that are implicated in cancer development or treatment. The properties of the target metabolites at low concentration levels in biological samples frequently present unique challenges for sample preparation and analysis. With validated metabolomics methods offered in the lab, the omics data analysis can also be challenging, particularly since biological and health outcomes are dictated by exposures to drugs or multiple agents often requiring simultaneous measurements of multi-panel biomarkers of a cancer or a treatment and integrated informatics and statistical analysis of the resulting big data? sets. MeSR addresses these challenges through the following Specific Aims: 1) provide consultation in the design and execution of studies that require use of metabolomics platform technologies for cancer research; 2) provide expertise in method development including sample preparation to enable detection and quantitation of low-concentration or volatile metabolites in complex samples; 3) provide consultation and practical assistance with statistical and informatics methods for the analysis of metabolomics datasets generated using the services described in the preceding aims; and 4) provide education and training in metabolomics methods for cancer research. MeSR is operated by experienced professional staff with effective mechanisms in place for technical oversight, control and monitoring of instrument scheduling and access, data archiving and analysis, quality control and quality assurance. The lab has sufficient capacity to accommodate new research initiated from UHCC research programs; effective use of these facilities by researchers often requires new method development, initial feasibility studies, and assay validation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA071789-19
Application #
9737849
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
19
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Hawaii
Department
Type
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Marciel, Michael P; Khadka, Vedbar S; Deng, Youpeng et al. (2018) Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis. Oncotarget 9:13407-13422
Park, S-Y; Wilkens, L R; Maskarinec, G et al. (2018) Weight change in older adults and mortality: the Multiethnic Cohort Study. Int J Obes (Lond) 42:205-212
Gong, J; Nishimura, K K; Fernandez-Rhodes, L et al. (2018) Trans-ethnic analysis of metabochip data identifies two new loci associated with BMI. Int J Obes (Lond) 42:384-390
Pokhrel, Pallav; Herzog, Thaddeus A; Fagan, Pebbles et al. (2018) E-cigarette Advertising Exposure, Explicit and Implicit Harm Perceptions, and E-Cigarette use Susceptibility Among Non-Smoking Young Adults. Nicotine Tob Res :
Wu, Eric M; Hernandez, Brenda Y; Wong, Linda L (2018) Hepatocellular carcinoma in Micronesians, a growing Pacific Islander population in the U.S. Open J Gastroenterol 8:
Murphy, Sharon E; von Weymarn, Linda B; Parenteau, Marc et al. (2018) Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers. Chem Res Toxicol 31:168-175
Loo, Lenora W M; Williams, Makana; Hernandez, Brenda Y (2018) The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic U.S. Population. Cancer Epidemiol 58:71-76
Hernandez, Brenda Y; Tareg, Aileen C; Reichhardt, Martina et al. (2018) Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population. J Glob Health Rep 2:
Gu, Yuanzhuo; Wei, Xiyang; Sun, Yulin et al. (2018) miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features. Cancer Res :
Lim, Unhee; Monroe, Kristine R; Buchthal, Steve et al. (2018) Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups. Gastroenterology :

Showing the most recent 10 out of 562 publications